Saturday Edition
Stay updated with Archyde – your source for breaking news, global headlines, economy, entertainment, health, technology, and sports. Fresh stories daily.
A monoclonal antibody called EVT894 demonstrated promise as both a treatment and preventive measure for chikungunya virus infection in a first-in-human randomized, double-blind, placebo-controlled study presented at ESCMID Global. Conducted ... Read More
Continuous Coverage
Los Angeles Dodgers star Shohei Ohtani met with a 100-year-old survivor of the 1945 atomic bombing of Nagasaki…
Monaco’s basketball heart skipped a beat on Saturday night as LDLC ASVEL delivered a statement victory that sent…
Vercel, the Web3-focused hosting and deployment platform, confirmed a security breach on April 19, 2026, after a threat…
Allergy season is starting earlier in many regions due to warmer temperatures triggering earlier plant pollination, with the…
Comedian Jim Breuer brings his “Identify the Funny!” tour to New Brunswick’s State Theatre on Saturday, May 2,…
Spark, a Microsoft-backed AI workflow automation platform, announced that its integration with Microsoft Copilot saves an average of…
Global Affairs
On April 19, 2026, Chinese commentator Shanhui Zhang stated during L’Heure Inter that no official announcement had been…
Markets And Money
On April 19, 2026, NASA confirmed that the Voyager 1 spacecraft’s plasma wave instrument—operational for nearly 50 years…
Digital Culture
This week, Bethesda quietly deployed a free, narrative-rich expansion to The Elder Scrolls V: Skyrim via its Creation…
Science And Wellbeing
Following the April 2026 release of a community letter in Maple Ridge News titled “COVID lessons were not…
Screen And Sound
French cinema icon Nadia Farès, 57, passed away on April 17, 2026, following a cardiac event, prompting an…
Fixtures And Form
As of April 19, 2026, Kingersheim’s hopes of winning the Nationale 3 Group G title and securing promotion…
